ABIOMED Inc (NASDAQ:ABMD)
| 377.33 Delayed Data As of Dec 02 |  -0.11 / -0.03%Today’s Change | 219.85 Today|||52-Week Range 381.99 | +5.06% Year-to-Date |
Latest ABMD News | Press Releases
| 3 Healthcare Stocks to Buy and Hold for the Next 10 Years Dec 02 / MotleyFool.com - Paid Partner Content | Here's Why You Should Hold on to Abiomed (ABMD) Stock Now Nov 22 / Zacks.com - Paid Partner Content |
| Why Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report? Dec 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 377.44 |
| Today’s open | 376.70 |
| Day’s range | 376.63 - 378.00 |
| Volume | 37,441 |
| Average volume (3 months) | 689,573 |
| Market cap | $17.0B |
Data as of 3:59pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -39.88% |
| Earnings growth (this year) | +11.30% |
| Earnings growth (next 5 years) | +18.16% |
| Revenue growth (last year) | +21.74% |
| P/E ratio | 64.7 |
| Price/Sales | 14.73 |
| Price/Book | 11.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | +2.15 | +0.89% |
| SAUHFStraumann Holding AG | +1.95 | +1.72% |
| PODDInsulet Corp | 0.00 | 0.00% |
| TFXTeleflex Inc | -2.22 | -0.91% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $1.18 |
| Annual revenue (last year) | $1.0B |
| Annual profit (last year) | $136.5M |
| Net profit margin | 13.23% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |
Forecasts
